March 2007
Chronicle of Philanthropy - will receive a joint gift of $100-million to conduct research into the genetic origin of schizophrenia, bipolar depression, and the genetic basis of mental illnesses, the new center will screen chemicals in a search for novel modes of treatment
Source: philanthropy.com
Preliminary Program: Wednesday, May 23
Psychiatric News - Implications for the Treatment of Substance Abuse National Institute on Drug Abuse; Chair: Steven J. Grant, Ph.D. IW57 The Role of Quetiapine in the Management of Acute Bipolar Depression (With a Focus on Bipolar II Patients) Michael E. Thase, M.D.
Source: pn.psychiatryonline.org
The Treatment of Elderly Patients With Bipolar Disorder CME/CE
Medscape News - Lamotrigine use in geriatric patients with bipolar depression. Can J Psychiatry. 2002;47:767-770. Abstract Sajatovic M, Gyulai L, Calabrese JR, et al. Maintenance treatment outcomes in older patients with bipolar I disorder. Am J Geriatr Psychiatry
Source: www.medscape.com
Preliminary Program: Saturday, May 19
Psychiatric News - Neurobiology of Bipolar Depression: Implications for Treatment Robert M. Post, M.D. New Treatment Options for Bipolar Depression Marcia L. Verduin, M.D. Clinical Correlates Associated With Treatment-Emergent Mania Mark A. Frye, M.D. The Clinical Interface
Source: pn.psychiatryonline.org
U.S. Clears Seroquel for Bipolar Depression
Medscape News - LONDON (Reuters) Oct 20 - AstraZeneca Plc said on Friday it had won U.S. approval for Seroquel (quetiapine) to be sold as treatment for bipolar depression. The antipsychotic drug had already been cleared by the Food and Drug Administration as a
Source: www.medscape.com
Click here for more information about depression treatment center depression treatment center
<< Home